Hemoglobin glycation index as a useful predictor of therapeutic responses to dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes.

about

Comparative Study on Adding Pioglitazone or Sitagliptin to Patients with Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin.

P2860

Q49193708-4D487FAE-27D9-4B6A-AB06-9474B9CED6A7

P2860

Hemoglobin glycation index as a useful predictor of therapeutic responses to dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes.

Item

http://www.wikidata.org/entity/Q36275557

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Hemoglobin glycation index as ...... patients with type 2 diabetes.

@ast

Hemoglobin glycation index as ...... patients with type 2 diabetes.

@en

type

Item

label

Hemoglobin glycation index as ...... patients with type 2 diabetes.

@ast

Hemoglobin glycation index as ...... patients with type 2 diabetes.

@en

prefLabel

Hemoglobin glycation index as ...... patients with type 2 diabetes.

@ast

Hemoglobin glycation index as ...... patients with type 2 diabetes.

@en

P1476

Hemoglobin glycation index as ...... patients with type 2 diabetes.

@en

P2093

Chia-Lin Lee

http://www.w3.org/2001/XMLSchema#string

Chia-Po Fu

http://www.w3.org/2001/XMLSchema#string

Jun-Sing Wang

http://www.w3.org/2001/XMLSchema#string

Shih-Yi Lin

http://www.w3.org/2001/XMLSchema#string

Wayne H-H Sheu

http://www.w3.org/2001/XMLSchema#string

Yu-Wei Chen

http://www.w3.org/2001/XMLSchema#string

Yuh-Min Song

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and insulin resistance

A nomogram to estimate the HbA1c response to different DPP-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of 98 trials with 24 163 patients

Persistence of individual variations in glycated hemoglobin: analysis of data from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial

Ambulatory treatment of type 2 diabetes in the U.S., 1997-2012.

Inflammation in the pathogenesis of microvascular complications in diabetes.

The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial

Association between Inflammation and Biological Variation in Hemoglobin A1c in U.S. Nondiabetic Adults.

Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and meta-analysis.

Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition.

Targeting inflammation in the treatment of type 2 diabetes.

P304

e0171753

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0171753

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

I-Te Lee

P577

2017-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28182722

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

5300176

http://www.w3.org/2001/XMLSchema#string

Hemoglobin glycation index as a useful predictor of therapeutic responses to dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes.

about

P2860

P2860

Hemoglobin glycation index as a useful predictor of therapeutic responses to dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932